Analysis of the genetic expression data from CCLE indicated that METTL16 (Figure 2F) and ALKBH5 (Supplementary Figure S5) expression levels were lower in PDA cell lines than in most other cancer cell lines. Here, ALKBH5 is linked to Patent ductus arteriosus.